A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

Clinical trial NCT00405327 · COMPLETED

Trial details

NCT number: NCT00405327
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma Neuroblastoma Wilm's Tumor

Start date: 2006-06-01
Primary completion: 2009-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.